|
|
 |
|
|
Clinical Publications
Lazar H, Horn MP, Zuercher AW, Imboden MA, Durrer P, Seiberling M, Pokorny R, Hammer C, Lang AB. "Pharmacokinetics and safety profile of the human anti-Pseudomonas aeruginosa serotype O11 immunoglobulin M monoclonal antibody KBPA -101 in healthy volunteers". Antimicrob Agents Chemother. 2009 Aug;53(8):3442-6. Epub 2009 May
Horn MP, Zuercher AW, Imboden MA, Rudolf MP, Lazar H, Wu H, Hoiby N, Fas SC, Lang AB, "Preclinical In Vitro and In Vivo characterization of the fully human monoclonal IgM Antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11". Antimicrob Agents Chemother. June 2010, p. 2338?2344 Vol. 54 No. 6
Tarköy M, Wyss M, Rudolf MP, "A comparative characterization of dipentameric (IgM)(2) and pentameric IgM species present in preparations of a monoclonal IgM for therapeutic use". J Pharm Biomed Anal 51 (5), 1084-1090 (2010 |
|
|
